Clinical Trial Update: Proof of Concept (POC) in Patients With Ischaemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial in ischemic stroke sponsored by GlaxoSmithKline was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cerebrovascular Accident | Phase 2 | Status: TERMINATED | Results posted: 2017-10-03